Joanna Kopecka

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 21

Top Topics

Chronic Myeloid Leukemia

Reactive Oxygen Species

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Cristina Panuzzo, Lucrezia Pironi, Alessandro Maglione, Simone Rocco, Serena Stanga, Chiara Riganti, Joanna Kopecka, Muhammad Shahzad Ali, Barbara Pergolizzi, Enrico Bracco, Daniela Cilloni
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International journal of molecular sciences 24 (2) (2023)
Daniel L Pouliquen, Giacomo Ortone, Letizia Rumiano, Alice Boissard, Cécile Henry, Stéphanie Blandin, Catherine Guette, Chiara Riganti, Joanna Kopecka
Long-Chain Acyl Coenzyme A Dehydrogenase, a Key Player in Metabolic Rewiring/Invasiveness in Experimental Tumors and Human Mesothelioma Cell Lines. Cancers 15 (11) (2023)
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International journal of molecular sciences 24 (1) (2023)
Cristina Panuzzo, Lucrezia Pironi, Alessandro Maglione, Simone Rocco, Serena Stanga, Chiara Riganti, Joanna Kopecka, Muhammad Shahzad Ali, Barbara Pergolizzi, Enrico Bracco, Daniela Cilloni
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International journal of molecular sciences 24 (2) (2023)
Cristina Panuzzo, Lucrezia Pironi, Alessandro Maglione, Simone Rocco, Serena Stanga, Chiara Riganti, Joanna Kopecka, Muhammad Shahzad Ali, Barbara Pergolizzi, Enrico Bracco, Daniela Cilloni
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International journal of molecular sciences 24 (2) (2023)
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International journal of molecular sciences 24 (1) (2023)
Cristina Panuzzo, Lucrezia Pironi, Alessandro Maglione, Simone Rocco, Serena Stanga, Chiara Riganti, Joanna Kopecka, Muhammad Shahzad Ali, Barbara Pergolizzi, Enrico Bracco, Daniela Cilloni
mTORC2 Is Activated under Hypoxia and Could Support Chronic Myeloid Leukemia Stem Cells. International journal of molecular sciences 24 (2) (2023)
Dario P Anobile, Iris Chiara Salaroglio, Fabrizio Tabbò, Sofia La Vecchia, Muhlis Akman, Francesca Napoli, Maristella Bungaro, Federica Benso, Elisabetta Aldieri, Paolo Bironzo, Joanna Kopecka, Francesco Passiglia, Luisella Righi, Silvia Novello, Giorgio Vittorio Scagliotti, Chiara Riganti
Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Claudia Maria Hattinger, Iris Chiara Salaroglio, Leonardo Fantoni, Martina Godel, Chiara Casotti, Joanna Kopecka, Katia Scotlandi, Toni Ibrahim, Chiara Riganti, Massimo Serra
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. International journal of molecular sciences 24 (1) (2023)
Iris Chiara Salaroglio, Dimas Carolina Belisario, Paolo Bironzo, Preeta Ananthanarayanan, Luisa Ricci, Sabrina Digiovanni, Simona Fontana, Francesca Napoli, Alberto Sandri, Chiara Facolmatà, Roberta Libener, Valentina Comunanza, Federica Grosso, Elena Gazzano, Francesco Leo, Riccardo Taulli, Federico Bussolino, Luisella Righi, Mauro Giulio Papotti, Silvia Novello, Giorgio Vittorio Scagliotti, Chiara Riganti, Joanna Kopecka
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Joanna Kopecka
Mitochondria-Targeted Drug Delivery. Pharmaceutics 14 (1) (2022)
Virginia Campani, Iris Chiara Salaroglio, Valeria Nele, Joanna Kopecka, Andreas Bernkop-Schnürch, Chiara Riganti, Giuseppe De De Rosa
Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors. Pharmaceutics 14 (2) (2022)
Sara Petrillo, Francesco De Giorgio, Joanna Kopecka, Tullio Genova, Veronica Fiorito, Anna Lucia Allocco, Francesca Bertino, Deborah Chiabrando, Federico Davide Mussano, Fiorella Altruda, Luca Munaron, Chiara Riganti, Emanuela Tolosano
Endothelial Heme Dynamics Drive Cancer Cell Metabolism by Shaping the Tumor Microenvironment. Biomedicines 9 (11) (2021)
Martina Godel, Giacomo Ortone, Dario Pasquale Anobile, Martina Pasino, Giulio Randazzo, Chiara Riganti, Joanna Kopecka
Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer. Pharmaceutics 13 (5) (2021)
Daniel L Pouliquen, Joanna Kopecka
Malignant Mesothelioma. Cancers 13 (14) (2021)
Cecilia Roux, Gianluca Mucciolo, Joanna Kopecka, Francesco Novelli, Chiara Riganti, Paola Cappello
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine. Antioxidants (Basel, Switzerland) 10 (3) (2021)
Candida Vitale, Valentina Griggio, Chiara Riganti, Maria Todaro, Joanna Kopecka, Rebecca Jones, Chiara Salvetti, Elia Boccellato, Francesca Perutelli, Claudia Voena, Laura Godio, Mario Boccadoro, Marta Coscia
Targeting HIF-1α Regulatory Pathways as a Strategy to Hamper Tumor-Microenvironment Interactions in CLL. Cancers 13 (12) (2021)
Chiara Riganti, Roberta Giampietro, Joanna Kopecka, Costanzo Costamagna, Francesca Serena Abatematteo, Marialessandra Contino, Carmen Abate
MRP1-Collateral Sensitizers as a Novel Therapeutic Approach in Resistant Cancer Therapy: An In Vitro and In Vivo Study in Lung Resistant Tumor. International journal of molecular sciences 21 (9) (2020)
Dimas Carolina Belisario, Joanna Kopecka, Martina Pasino, Muhlis Akman, Enrico De Smaele, Massimo Donadelli, Chiara Riganti
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance. Cells 9 (12) (2020)
Martina Godel, Deborah Morena, Preeta Ananthanarayanan, Ilaria Buondonno, Giulio Ferrero, Claudia M Hattinger, Federica Di Nicolantonio, Massimo Serra, Riccardo Taulli, Francesca Cordero, Chiara Riganti, Joanna Kopecka
Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma. International journal of molecular sciences 21 (12) (2020)
Iris C Salaroglio, Elisa Panada, Enrico Moiso, Ilaria Buondonno, Paolo Provero, Menachem Rubinstein, Joanna Kopecka, Chiara Riganti
PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy. Molecular cancer 16 (1) (2017)